These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 4056902)

  • 21. Efficacy of prognostic factors on survival in patients with low grade glioma.
    Durmaz R; Vural M; Işildi E; Coşan E; Ozkara E; Bal C; Ciftçi E; Arslantaş A; Atasoy MA
    Turk Neurosurg; 2008 Oct; 18(4):336-44. PubMed ID: 19107679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors of clinical outcome in pediatric oligodendroglioma: meta-analysis of individual patient data and multiple imputation.
    Wang KY; Vankov ER; Lin DDM
    J Neurosurg Pediatr; 2018 Feb; 21(2):153-163. PubMed ID: 29192869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oligodendroglioma: CD44 as a possible prognostic opportunity.
    Buccoliero AM; Caldarella A; Arganini L; Mennonna P; Ammanati F; Taddei A; Taddei GL
    Clin Neuropathol; 2003; 22(4):169-75. PubMed ID: 12908752
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Results in oligodendroglioma: postoperative radiotherapy combined with chemotherapy].
    Kitahara M; Katakura R; Mashiyama S; Niizuma H; Yoshimoto T; Suzuki J; Mori T; Wada T
    No Shinkei Geka; 1987 Apr; 15(4):397-403. PubMed ID: 3614532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oligodendroglioma. An analysis of the value of radiation therapy.
    Bullard DE; Rawlings CE; Phillips B; Cox EB; Schold SC; Burger P; Halperin EC
    Cancer; 1987 Nov; 60(9):2179-88. PubMed ID: 3440228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oligodendrogliomas: the Mayo Clinic experience.
    Shaw EG; Scheithauer BW; O'Fallon JR; Tazelaar HD; Davis DH
    J Neurosurg; 1992 Mar; 76(3):428-34. PubMed ID: 1738022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oligodendroglioma: the Rotterdam-Dijkzigt experience.
    Kros JM; Pieterman H; van Eden CG; Avezaat CJ
    Neurosurgery; 1994 Jun; 34(6):959-66; discussion 966. PubMed ID: 8084406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological findings and five year survival rates for patients with central nervous system tumors in Yazd, Iran.
    Zahir ST; Vakili M; Navabii H; Rahmani K
    Asian Pac J Cancer Prev; 2014; 15(23):10319-23. PubMed ID: 25556468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oligodendrogliomas in the CT/MR-era.
    Leonardi MA; Lumenta CB
    Acta Neurochir (Wien); 2001 Dec; 143(12):1195-203. PubMed ID: 11810382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival analysis of presumptive prognostic markers among oligodendrogliomas.
    McLendon RE; Herndon JE; West B; Reardon D; Wiltshire R; Rasheed BK; Quinn J; Friedman HS; Friedman AH; Bigner DD
    Cancer; 2005 Oct; 104(8):1693-9. PubMed ID: 16116609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of location on outcome in children with low-grade oligodendroglioma.
    Peters O; Gnekow AK; Rating D; Wolff JE
    Pediatr Blood Cancer; 2004 Sep; 43(3):250-6. PubMed ID: 15266409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective review of prognostic factors, including 1p19q deletion, in low-grade oligodendrogliomas and a review of recent published works.
    Capelle L; Oei P; Teoh H; Hamilton D; Palmer D; Low I; Campbell G
    J Med Imaging Radiat Oncol; 2009 Jun; 53(3):305-9. PubMed ID: 19624298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oligodendrogliomas in Children: Clinical Experiences With 20 Patients.
    Wu CT; Tsay PK; Jaing TH; Chen SH; Tseng CK; Jung SM
    J Pediatr Hematol Oncol; 2016 Oct; 38(7):555-8. PubMed ID: 27299589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Results of the Sainte-Anne - Lyons series of 318 oligodendroglioma in adults].
    Nataf F; Koziak M; Ricci AC; Varlet P; Devaux B; Beuvon F; Roujeau T; Page P; Cioloca C; Turak B; Schlienger M; Touboul E; Haie-Meder C; Vannetzel JM; Dhermain F; Honnorat J; Jouvet A; De Saint-Pierre G; Daumas-Duport C; Bret P; Roux FX
    Neurochirurgie; 2005 Sep; 51(3-4 Pt 2):329-51. PubMed ID: 16292177
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Long-term results of treatment in patients with oligodendrogliomas and oligoastrocytomas of the cerebral hemispheres].
    Iun'pén V; Oliushin VE; Ulitin AIu; Maslova LN; Petrov AA
    Zh Vopr Neirokhir Im N N Burdenko; 2008; (2):6-10; discussion 10-1. PubMed ID: 18720725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conventional and advanced (DTI/SWI) neuroimaging findings in pediatric oligodendroglioma.
    Wagner MW; Poretti A; Huisman TA; Bosemani T
    Childs Nerv Syst; 2015 Jun; 31(6):885-91. PubMed ID: 25813856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in diagnosis and management of oligodendroglioma.
    Hussein MR; Baidas S
    Expert Rev Anticancer Ther; 2002 Oct; 2(5):520-8. PubMed ID: 12382520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do epileptic seizures predict outcome in patients with oligodendroglioma?
    Mirsattari SM; Chong JJ; Hammond RR; Megyesi JF; Macdonald DR; Lee DH; Cairncross JG
    Epilepsy Res; 2011 Mar; 94(1-2):39-44. PubMed ID: 21315558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined treatment modality for anaplastic oligodendroglioma and oligoastrocytoma: a 10-year update of a phase II study.
    Jeremic B; Milicic B; Grujicic D; Samardzic M; Antunovic V; Dagovic A; Aleksandrovic J
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):509-14. PubMed ID: 15145170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pediatric and adolescent oligodendrogliomas.
    Tice H; Barnes PD; Goumnerova L; Scott RM; Tarbell NJ
    AJNR Am J Neuroradiol; 1993; 14(6):1293-300. PubMed ID: 8279322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.